Cherr Gregory S, Hansen Kimberley J, Craven Timothy E, Edwards Matthew S, Ligush John, Levy Pavel J, Freedman Barry I, Dean Richard H
Division of Surgical Sciences, Section on Vascular Surgery, Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157-195, USA.
J Vasc Surg. 2002 Feb;35(2):236-45. doi: 10.1067/mva.2002.120376.
This review describes the clinical outcome of surgical intervention for atherosclerotic renovascular disease in 500 consecutive patients with hypertension.
From January 1987 to December 1999, 626 patients underwent operative renal artery (RA) repair at our center. A subgroup of 500 patients (254 women and 246 men; mean age, 65 plus minus 9 years) with hypertension (mean blood pressure, 200 plus minus 35/104 plus minus 21 mm Hg) and atherosclerotic RA disease forms the basis of this report. Hypertension response was determined from preoperative and postoperative blood pressure measurements and medication requirements. Change in renal function was determined with estimated glomerular filtration rates (EGFRs) calculated from serum creatinine levels. Proportional hazards regression models were used for the examination of associations between selected preoperative parameters, blood pressure and renal function response, and eventual dialysis-dependence or death.
Two hundred three patients underwent unilateral RA procedures, 297 underwent bilateral RA procedures, and 205 patients underwent combined renal and aortic reconstruction. After surgery, there were 23 deaths (4.6%) in the hospital or within 30 days of surgery. Significant and independent predictors of perioperative death included advanced age (P <.0001; hazard ratio [HR], 3.23; 95% confidence interval [CI], 1.85 to 5.70) and clinical congestive heart failure (P =.013; HR, 3.05; 95% CI, 1.26 to 7.34). Among the patients who survived surgery, hypertension was considered cured in 12%, improved in 73%, and unchanged in 15%. For the entire group, renal function increased significantly after operation (preoperative versus postoperative mean EGFR, 41.1 plus minus 23.9 versus 48.2 plus minus 25.5 mL/min/m(2); P <.0001). For individual patients, with a 20% or more change in EGFR considered significant, 43% had improved renal function (including 28 patients who were removed from dialysis-dependence), 47% had unchanged function, and 10% had worsened function. Preoperative renal insufficiency (P <.001; HR, 2.35; 95% CI, 1.86 to 2.98), diabetes mellitus (P =.007; HR, 2.14; 95% CI, 1.15 to 3.97), prior stroke (P =.042; HR, 1.50; 95% CI, 1.02 to 2.22), and severe aortic occlusive disease (P =.003; HR, 1.69; 95% CI, 1.19 to 2.31) showed significant and independent associations with death or dialysis during the follow-up examination period. After operation, blood pressure cured (P =.014; HR, 0.52; 95% CI, 0.30 to 0.88) and improved renal function (P =.011; HR, 0.40; 95% CI, 0.19 to 0.81) showed significant and independent associations with improved dialysis-free survival rate. All categories of function response and time to death or dialysis showed significant interactions with preoperative EGFR.
The surgical correction of atherosclerotic renovascular disease resulted in blood pressure benefit and retrieval of renal function in selected patients with hypertension. The patients with cured hypertension or improved EGFR after operation showed increased dialysis-free survival as compared with other patients who underwent surgery.
本综述描述了500例连续性高血压患者接受动脉粥样硬化性肾血管疾病手术干预后的临床结局。
1987年1月至1999年12月,626例患者在本中心接受了肾动脉(RA)修复手术。本报告以500例高血压(平均血压200±35/104±21 mmHg)和动脉粥样硬化性RA疾病患者(254例女性和246例男性;平均年龄65±9岁)为基础。根据术前和术后血压测量值及药物需求确定高血压反应。通过根据血清肌酐水平计算的估计肾小球滤过率(EGFR)来确定肾功能变化。采用比例风险回归模型检验选定的术前参数、血压和肾功能反应与最终透析依赖或死亡之间的关联。
203例患者接受了单侧RA手术,297例接受了双侧RA手术,205例患者接受了肾脏和主动脉联合重建手术。术后,23例患者(4.6%)在住院期间或术后30天内死亡。围手术期死亡的显著且独立预测因素包括高龄(P<.0001;风险比[HR],3.23;95%置信区间[CI],1.85至5.70)和临床充血性心力衰竭(P =.013;HR,3.05;95%CI,1.26至7.34)。在手术存活的患者中,12%的高血压被认为治愈,73%有所改善,15%无变化。对于整个组,术后肾功能显著增加(术前与术后平均EGFR,41.1±23.9对48.2±25.5 mL/min/m²;P<.0001)。对于个体患者,EGFR变化20%或更多被认为有显著意义,43%的患者肾功能改善(包括28例不再依赖透析的患者),47%的患者功能无变化,10%的患者功能恶化。术前肾功能不全(P<.001;HR,2.35;95%CI,1.86至2.98)、糖尿病(P =.007;HR,2.14;95%CI,(1.15至)3.97)、既往中风(P =.042;HR,1.50;95%CI,1.02至2.22)和严重主动脉闭塞性疾病(P =.003;HR,1.69;95%CI,1.19至2.31)在随访检查期间与死亡或透析有显著且独立的关联。术后,血压治愈(P =.014;HR,0.52;95%CI,0.30至0.88)和肾功能改善(P =.011;HR,0.40;95%CI,0.19至0.81)与无透析生存率提高有显著且独立的关联。所有功能反应类别和至死亡或透析的时间与术前EGFR均有显著交互作用。
动脉粥样硬化性肾血管疾病的手术矫正使部分高血压患者的血压得到改善,肾功能得以恢复。术后高血压治愈或EGFR改善的患者与其他接受手术的患者相比,无透析生存率增加。